SagarSureshPatelMD

Hematologic Oncology

Assistant Professor at Huntsman Cancer Institute, University of Utah

Dr. Patel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I completed my internal medicine residency at the University of Minnesota, where I developed my interest in Blood and Marrow Transplantation (BMT). I then completed my Hematology and Medical Oncology fellowship at the Cleveland Clinic. I then completed an additional fellowship year in BMT. I am currently an Assistant Professor at the University of Utah, Huntsman Cancer Institute, Blood and Marrow Transplant Program.

Hematologic oncology, Myeloproliferative disorders, Myelofibrosis, Hematopoietic stem cell transplantation, Hodgkin's lymphoma, Multiple myeloma, Hematology, Lymphoma, Myelodysplastic syndromes , Medical oncology, Leukemia, CAR T-cell Therapy

Cleveland Clinic FoundationFellowship, Blood & Bone Marrow Transplant, 2018 - 2019
Cleveland Clinic FoundationResidency, Hematology and Medical Oncology, 2019
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2015 - 2018
University of MinnesotaResidency, Internal Medicine, 2013 - 2015
University of MinnesotaInternship, Internal Medicine, 2012 - 2012
University of Minnesota Medical SchoolClass of 2012
University of MinnesotaBS, Biology and Physiology, Summa Cum Laude, 2004 - 2008

PubMed

2 citations
Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.
Tania Jain, Noel Estrada-Merly, M Queralt Salas, Soyoung Kim, Jakob DeVos
Blood Advances. 2024-08-27
Intraorbital amphotericin B for mucormycosis in an Allo-HSCT recipient.
Wyatt Schwartz, Adam C Christiansen, Sagar S Patel
Bone Marrow Transplantation. 2024-08-01
10 citations
Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
Matt S Zinter, Ruta Brazauskas, Joelle Strom, Stella Chen, Stephanie Bo-Subait
Blood Advances. 2024-02-27

Journal Articles

Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation
Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature

Abstracts/Posters

Primary Plasma Cell Leukemia Outcomes Remain Dismal Despite Novel Agents and Hematopoietic Cell Transplantation
Sagar Patel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Optimizing Outcomes with Myeloablative Conditioning in Older Patients: Efficacy and Safety of Precision Engineered Orca-T in Patients > 55 Years Old with Hematologic MalignanciesDecember 2023
2019 TCT: Developments in Graft Versus Host DiseaseFebruary 2019
2019 TCT: Developments in Graft Versus Host DiseaseFebruary 2019
ASH 2018: Hope for SCD Within REACHDecember 2018
Join now to see all

Graft Composition in Allogeneic Hematopoietic Cell Transplantation May Be Associated with Patient OutcomesJanuary 14th, 2019
Hope for SCD Within REACHDecember 13th, 2018

Google Scholarhttp://scholar.google.com/citations?user=KiNOhO8AAAAJ&hl
My NCBI Bibliographyhttps://www.ncbi.nlm.nih.gov/myncbi/1NEDjSreMQxk2/bibliography/public/
University of Utah Profilehttps://healthcare.utah.edu/fad/mddetail.php?physicianID=u6025680&name=sagar-s-patel